1.     E. Carboni, E. Acquas, P. Leone, L. Perezzani and G. Di Chiara: 5-HT₃ receptors antagonists block morphine-and nicotine-induced place-preference conditioning.  Eur. J. Pharmacol. (1988) 151: 159-160.

2.     E. Acquas, E. Carboni, P. Leone and G. Di Chiara: 5-HT₃ receptors antagonists block morphine- and nicotine-but not amphetamine-induced place-preference conditioning.  Pharmacol. Res. Comm. (1988) 20, 12, 1113-1114.

3.     E. Carboni, E. Acquas, P. Leone and G. Di Chiara: 5HT₃ receptor antagonists block morphine- and nicotine-but not amphetamine-induced reward.  Psychopharmacol. (1989) 97: 175-178.

4.     E. Carboni, E. Acquas, R. Frau and G. Di Chiara: Differential inhibitory effects of a 5HT₃ antagonist on drug-induced stimulation of dopamine release. Eur. J. Pharmacol. (1989) 164: 515-519.

5.     E. Acquas, E. Carboni, P. Leone and G. Di Chiara: SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?  Psychopharmacol. (1989) 99: 151-155.

6.     E. Acquas, E. Carboni, L. Garau and G. Di Chiara: Blockade of acquisition of drug-conditioned place aversion by 5HT₃ antagonists.  Psychopharmacol. (1990) 100: 459-463.

7.     G. Di Chiara, E. Acquas and E. Carboni: Dopamine and drug-induced motivation. Advances in Biosciences, (1990) 77, 27-37, Eds. G.L. Gessa and G. Serra, Pergamon Press.

8.     E. Acquas, E. Carboni and G. Di Chiara: Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats.  Eur. J. Pharmacol. (1991) 193: 133-134.

9.     G. Di Chiara, E. Acquas and E. Carboni: Role of mesolimbic dopamine in the motivational effects of drugs. Brain Dialysis and place-preference studies. The mesolimbic dopamine system: from motivation to action. (1991) 367-384, Eds. P. Willner and J. Scheel-Kruger, J. Wilney & Sons, Ltd.

10.            E. Acquas, E. Carboni, R.H.A. de Ree, M. Da Prada and G. Di Chiara: Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-o-methyl transferase inhibitor, Ro 40-7592.  J. Neurochem. (1992) 59, 326-330.

11.            E. Acquas and G. Di Chiara: Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence.  J. Neurochem. (1992), 58, 1620-1625.

12.            G. Di Chiara, M. Morelli, E. Acquas and E. Carboni: Functions of dopamine in the extrapiramidal and limbic systems.  Arzneimittel Forschung Drug Research, 42 (I), 231- 237, Februar 1992 (2a)

13.            G. Di Chiara, E. Acquas and E. Carboni: Drug motivation and abuse: a neurobiologial perspective.  Annals of the “New York Academy of Sciences” (1992) 654, 207-219.

14.            E. Acquas, M. Meloni and G. Di Chiara: Blockade of d opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release.  Eur. J. Pharmacol. (1993) 230: 239-241.

15.            G. Di Chiara, E. Acquas, G. Tanda and C. Cadoni: Drugs of abuse: biochemical surrogates of specific aspects of natural reward?  In: Biochemical Soc. Symp. (1993) 59, 65-81 - Wonnecot and Stolerman Eds., Portland Press, London

16.            E. Acquas, J. C. Day and H. C. Fibiger: The potent and selective dopamine D₁ receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat.  Eur. J. Pharmacol. (1994) 260: 85-87.

17.            E. Acquas and G. Di Chiara: D₁ receptor blockade stereospecifically impairs the acquisition of drug-conditioned place preference and place aversion.  Behav. Pharmacol. (1994) 5: 555-569.

18.            E. Acquas and H. C. Fibiger: Chronic lithium attenuates dopamine D1-receptor mediated increases in acetylcholine release in rat frontal cortex. Psychopharmacology (1996) 125(2), 162-167.

19.            G. Di Chiara, E. Acquas and G. Tanda: Ethanol as a neurochemical surrogate of conventional reinforcers: the dopamine-opioid link. Alchool (1996) 13 (1): 13-17.

20.            E. Acquas, C. Wilson and H. C. Fibiger: Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear. J. Neuroscience (1996) 16(9): 3089-3096.

21.            E. Acquas, C. Wilson and H. C. Fibiger: Non striatal dopamine D1 receptors regulate striatal acetylcholine release in vivo. J. Pharmacol. Exper. Ther. (1997) 281(1): 360-368.

22.            G. Di Chiara, G. Tanda, C. Cadoni, E Acquas, V. Bassareo and E. Carboni: Homologies and differences in the action of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence.  In: Advances in Pharmacology, (1998) Vol. 42, 983-987.

23.            E. Acquas, C. Wilson and H. C. Fibiger: Pharmacology of sensory stimulation-evoked increases in frontal cortical acetylcholine release. Neuroscience,(1998), 85 (1), 73-83.

24.            E. Acquas and H. C. Fibiger: Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition. J. Neurochem. (1998), 70, 1088-1093.

25.            E. Acquas, S. Fenu, P. Loddo and G. Di Chiara: A within-subjects microdialysis/behavioural study of the role of striatal acetylcholine in D₁-dependent turning. Behav. Brain Res. (1999), 103, 219-228.

26.            G. Di Chiara, G. Tanda, V. Bassareo, F. Pontieri, E. Acquas, S. Fenu, C. Cadoni and E. Carboni:  Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann N Y Acad Sci. (1999) Jun 29;877:461-85.

27.            G. Di Chiara, O. Giorgi ed E. Acquas: I Neurotrasportatori.  In:  Trattato di Farmacologia Generale. (1999)  UTET editore, 1999, 242-262.

28.            E. Acquas and G. Di Chiara:  Dopamine D₁ receptor mediated control of striatal acetylcholine release by endogenous dopamine.  Eur. J. Pharmacol., (1999) 383(1), 121-127.

29.            E. Acquas and G. Di Chiara:  Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum. Eur. J. Pharmacol., (1999) 383(3) 275-279.

30.            E. Acquas: Molecular pharmacology and neuroanatomy of alcohol: translation into clinical practice.  In::  CRC Handbook of Alcoholism: Clinical and theoretical approaches . G. Zernig, A. Saria and M. Kurz, eds., CRC Press.(2000).

31.            E. Acquas, Pisanu A., Marrocu P. and G. Di Chiara:  Cannabinoid CB₁ receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo.  Eur. J. Pharmacol., (2000) 401, 179-185.

32.            P. Marrocu, A. Pisanu  and  E. Acquas:  Neurochemical mechanisms of dopamine-acetylcholine interactions.  Res. Adv. in Neurochem., (2000) 1, 35-41.

33.            E. Acquas, P. Marrocu, A. Pisanu, C. Cadoni, G. Zernig, A. Saria, and G. Di Chiara:  Intravenous administration of ecstasy (3,4-metylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo.  Eur. J. Pharmacol., (2001) 418, 207-211.

34.            E. Acquas, Pisanu A., Marrocu P., Goldberg S.R., and G. Di Chiara:  D⁹-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo:  a microdialysis study.  Eur. J. Pharmacol., (2001) 419, 155-161.

35.            E. Acquas and G. Di Chiara:  Role of dopamine D₁ receptors in the control of striatal acetylcholine release by endogenous dopamine.  Neurol. Sci., (2001) 21(1), 41-42.

36.            S. Fenu, E. Acquas and G. Di Chiara:  Role of striatal acetylcholine on dopamine D₁ receptor agonist-induced turning behavior in 6-hydroxydopamine lesioned rats:  a microdialysis-behavioral study. Neurol. Sci., (2001) 21(1), 63-64.

37.            C. Cadoni, A. Pisanu, M. Solinas, E. Acquas, and Gaetano Di Chiara:  Behavioural sensitization after repeated exposure to D⁹-tetrahydrocannabinol and cross-sensitization with morphine.  Psychopharmacology, (2001), 158(3), 259-266.

38.            E. Acquas, G. Tanda. P. Marrocu, A. Pisanu , and G. Di Chiara:  Effects of caffeine on dopamine and acetylcholine release and on short term memory function:  a brain microdialysis and spatial delayed alternation task study.  In:  Proceedings of the XIX Colloquium on Coffee Science, ASIC, (2001).

39.            M. Morelli, E. Acquas, and E. Ongini:  Dopamine–Adenosine interactions.  In:  Handbook of Experimental Pharmacology, Vol. X, (2002), Springer-Verlag,  Chapter 17,  pp. 135-150.

40.            E. Acquas, and G. Di Chiara:  Dopamine–Acetylcholine interactions.  In:  Handbook of Experimental Pharmacology, Vol. X, (2002), Springer-Verlag,  Chapter 15, pp. 85-115.

41.            E. Acquas, G. Tanda. P. and G. Di Chiara: Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats.  Neuropsychopharmacology (2002), 27(2), 182-193.

42.             E. Acquas, A Bachis, R. Nosheny, I. Cernak, and I. Mocchetti:  Human Immunodeficiency Virus type I protein gp120 causes neuronal cell death in the rat brain by activating caspases.  Neurotox. Res. (2004), 5(8), 605-615.

43.             Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E, Valentini V, Lecca D.Dopamine and drug addiction: the nucleus accumbens shell connection.  Neuropharmacology (2004),  47 (Suppl 1), 227-241. 

44.            Nosheny RL, Bachis A, Acquas E and Mocchetti I:  Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death.  Eur. J. Neurosci. (2004), 20,  2857-2864.